Feature | July 26, 2013

Healthcare Decision Support and IBM Watson — Market Shares, Strategies, Forecasts

July 26, 2013 — Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.


Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.


IBM Watson can provide a far more differentiated testing assessment and knows what tests are relevant to further characterize a particular patient condition and what tests are not. Having an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation is a great help to physicians. Wrong tests, tests that are not useful in a particular situation, account for 30 percent of the costs of healthcare delivery in the United States. 


IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is comprised of a powerful core engine. The first purpose that Watson has been put to is to improve healthcare delivery. 


For more information: www.researchandmarkets.com/research/v5ccjm/healthcare


Related Content

echocardiography, ASE, hypertrophic cardiomyopathy, HCM, interpretation, Narula
News | Cardiovascular Ultrasound| June 15, 2015
A research team from New York has announced advances in automated echocardiography decision systems that could help...
CDS, clinical decision support, Rand Corp., study, appropriateness
Feature | Clinical Decision Support| June 04, 2015
Using tools that help physicians decide whether to use expensive imaging studies can help reduce the ordering of...
Stage 3 MU, stage 3meaningful use, patient engagement

Patient engagement plays a key role in the Stage 3 MU rules, where patients are more involved in their health management and treatment decisions. Part of Stage 3 requires electronic patient access to all their medical records, enabled by patient portals, as in this example of Carestream's Vue Motion software.

Feature | Information Technology| May 07, 2015 | Dave Fornell
The Centers for Medicare and Medicaid Services (CMS) gathered public comments on its Stage 3 Meaningful Use (MU)...
News | Clinical Decision Support| April 29, 2015
COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board.
Videos | Information Technology| April 22, 2015
The Centers for Medicare and Medicaid (CMS) has issue a draft list Stage 3 Meaningful Use requirements.
Point of Care Decision Support, anticoagulation software, PCDS AC, therapy

Image courtesy of Point of Care Decision Support

News | Clinical Decision Support| March 11, 2015
Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and reduces adverse...
ACC, Guideline App, prevention, atrial fibrillation, clinical decision support
Technology | March 06, 2015
The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of...
ACR, Appropriateness Criteria, clinical decision support, update, March 2015
Technology | March 02, 2015
New and updated American College of Radiology (ACR) Appropriateness Criteria now help healthcare providers choose the...
Technology | February 18, 2015
Physicians who use the clinical reference tool, DynaMed from EBSCO Health, can now access the valuable, evidence-based...
News | January 29, 2015
The 2014 Best in KLAS report ranks healthcare vendors and their solutions by the professionals who use them—healthcare...
Overlay Init